1.45
1.45 (0%)
As of Feb 11, 2025
Ikena Oncology, Inc. [IKNA]
Source:
Company Overview
Ikena Oncology, Inc is a targeted oncology company developing precision medicines tailored to biomarker-defined patient groups with specific unmet needs. With our robust biomarker and translational approach we aim to develop targeted treatments and define patient populations who are most likely to respond to treatment.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | 857-343-8292 |
Industry | |
CEO | Mark Manfredi, Ph.D. |
Website | clinicaltrials.gov |